No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract BRAF inhibitor and BRAF inhibitor-based combination therapy were tolerable in treating melanoma for a real-world, Chinese population

byKathleen Lau

April 16, 2021

in StudyGraphics

Quality improvement initiative increases rates of evidence-based ventilation strategy in NICU

RelatedReports

Patients with advanced adenomas are at increased risk of developing colorectal cancer

AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026

AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026

Testosterone replacement in male cancer survivors helps improve body composition

Oncology

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Cardiology

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

January 26, 2026

Few high school students, young adults get HIV testing

Dolutegravir-containing antiretroviral regimens show effective viral suppression in pregnant women with HIV-1 infections

Physical therapy reduces pain in adults with knee osteoarthritis

2 Minute Medicine Rewind April 19, 2021

USPSTF finds insufficient evidence for screening for iron deficiency anemia during pregnancy

Continued versus discontinued oxytocin stimulation in the active phase of labour

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports